COUGHSPRAY: Rapid and Effective Relief for dry Cough

Overview

DRY COUGH is a groundbreaking product from Vitrobio, designed to provide a comprehensive solution for the treatment of cough. This product is a filmogen liquid bandage, presented as a 30ml throat spray, and is specifically formulated to combat both viral and bacterial throat infections that lead to coughing.

Targeted Proteins and Actions

The unique formulation of COUGHSPRAY targets pro-inflammatory proteins, contaminants, and impurities. Its mode of action is threefold:

Protective Barrier Effect: The filmogen liquid bandage acts as an absorbent barrier against incoming allergens and contaminants, providing immediate protection to the nasal mucosa.

Osmotic and Cleaning Effect: The high osmotic activity of the product instantly attracts and traps most of the adhered contaminants, including inflammatory proteins and allergens. This suppresses inflammation and the immune cascade, providing immediate relief from symptoms.

Cellular Repair and Growth Effect: By creating a clean and hydrated biological surface, DRY COUGH immediately triggers cell growth and healing. This helps restore the integrity of the nasal mucosa, further alleviating symptoms and promoting recovery.

Clinical Trial Results

The efficacy of COUGHSPRAY has been demonstrated in a randomized, double-blind, placebo-controlled trial over two weeks. The study included 54 patients, with 37 receiving the test product and 17 receiving the comparator. The results were impressive:

• Antibiotics: The requirement for antibiotics was significantly reduced in the test group (10.81% of patients) compared to the placebo group (82.35%).
• Severity: There was a 76% reduction in dry cough severity within 12 days.
• Frequency: There was a 98% reduction in dry cough frequency within 14 days.
• Throat Irritation: There was a 90% reduction in throat irritation within 12 days.
• Throat Pain: There was a 99% reduction in throat pain within 14 days.

These results demonstrate the effectiveness of OUGHSPRAY in providing rapid and lasting relief from the symptoms of cough, while also reducing the need for antibiotics. No side effects were recorded, further attesting to the safety of the product.

For more detailed information on the clinical study, please refer to the full text of the published research.

OUGHSPRAY by Vitrobio represents a new era in cough treatment, offering a safe, effective, and rapid solution to alleviate the symptoms and address the underlying causes of cough.

See full publication (PDF)

Main results

ANTIBIOTICS
Requirements for antibiotics strongly diminished in the test group (10.81 % patients) vs placebo group (82.35 %)

SEVERITY
15,81 % reduction in dry cough severity within 2 days.
32,08 % reduction in dry cough severity within 3 days.
46,39 % reduction in dry cough severity within 6 days.
62,65 % reduction in dry cough severity within 9 days.
76 % reduction in dry cough severity within 12 days

FREQUENCY
50 % reduction in dry cough frequency within 6 days.
80 % reduction in dry cough frequency within 12 days.
98 % reduction in dry cough frequency within 14 days.

THROAT IRRITATION
7,5 % reduction in throat irritation within 2 hours.
40 % reduction in throat irritation within 3 days.
60 % reduction in throat irritation within 6 days.
80 % reduction in throat irritation within 9 days.
90 % reduction in throat irritation within 12 days.

Throat irritation lower by 37,8 % within 3 days compare to the placebo group.
Throat irritation lower by 55,4 % within 6 days compare to the placebo group.
Throat irritation lower by 73,4 % within 9 days compare to the placebo group.
Throat irritation lower by 89,7 % within 12 days compare to the placebo group.

THROAT PAIN
19 % reduction in throat pain within 2 days.
38 % reduction in throat pain within 3 days.56 % reduction in throat pain within 6 days.
• 72 % reduction in throat pain within 9 days.
• 86 % reduction in throat pain within 12 days.
• 99 % reduction in throat pain within 14 days